Inventory Accounting Policy
Inventories are included in the financial statements at the lower of cost (including raw materials, direct labor, other direct costs and related production overheads) and net realizable value. Cost is generally determined on a first in, first out basis. Pre-launch inventory is held as an asset when there is a high probability of regulatory approval for the product. Before that point a provision is made against the carrying value to its recoverable amount; the provision is then reversed at the point when a high probability of regulatory approval is determined.
Source: GlaxoSmithKline PLC, Annual Report
Inventory Disclosure
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
GlaxoSmithKline PLC, Statement of Financial Position, Inventory
USD $ in millions, translated from GBP £
Source: Based on data from GlaxoSmithKline PLC Annual Reports
| Item |
Description |
The company |
| Raw materials and consumables |
Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. |
GlaxoSmithKline PLC's raw materials and consumables increased from 2008 to 2009 and from 2009 to 2010.
|
| Work in progress |
Carrying amount as of the balance sheet date of merchandise or goods which are partially completed, are generally comprised of raw materials, labor and factory overhead costs, and which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing. |
GlaxoSmithKline PLC's work in progress increased from 2008 to 2009 but then declined significantly from 2009 to 2010.
|
| Finished goods |
Carrying amount as of the balance sheet date of merchandise or goods held by the company that are readily available for sale. |
GlaxoSmithKline PLC's finished goods declined from 2008 to 2009 but then increased from 2009 to 2010 exceeding 2008 level.
|
| Inventories |
Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer). |
GlaxoSmithKline PLC's inventories increased from 2008 to 2009 but then declined significantly from 2009 to 2010.
|
